-transparent.png){kind=logo}
Blood concentrations of thyrotropin-releasing hormone (TRH, Protirelin) were measured by a specific radioimmunoassay in 16 euthyroid subjects after intravenous (200 micrograms), nasal (2 mg) or oral (40 mg) administration of TRH. TRH blood levels peaked 2 min after i.v. administration (13,400 +/- 1,020 fmol/ml), 10 min after nasal (5,000 +/- 1,800 fmol/ml) and 150 min after oral (2,650 +/- 1,080 fmol/ml) administration. The degradation of TRH followed an exponential curve, giving a half-life of 6.5 min. The disappearance rate gave a "half-life" of 22 min in the nasal application group and of 31 min in the oral group. Maximal concentration of stimulated thyrotropin-stimulating hormone (TSH) always occurred 30 min after the peak TRH concentration without any correlation with the TRH concentration time integrals, suggesting that TSH secretion is dependent on a continually rising TRH blood level.
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
October 1974,
Archives of general psychiatry,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
August 1997,
Obstetrics and gynecology,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
January 1985,
European journal of clinical pharmacology,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
January 1973,
Clinical pharmacology and therapeutics,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
November 1983,
American heart journal,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
March 1988,
Psychiatry research,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
January 1989,
Pharmacology & therapeutics,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
October 1991,
Minerva anestesiologica,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
July 1990,
The Journal of clinical endocrinology and metabolism,
L Duntas, and
F S Keck, and
U Loos, and
E F Pfeiffer
June 1984,
Archives of internal medicine,
